Curaleaf, a cannabis producer and retailer, has voluntarily recalled its Curaleaf Whole Flower 3.5g Auburn product after a stability test revealed elevated levels of yeast and mold. The Connecticut Department of Consumer Protection confirmed the recall on Friday.
The recall was initiated after the product’s 60-day stability test indicated that yeast and mold levels exceeded the acceptable range. Stability testing is crucial for determining how a product changes over time and helps establish its shelf life, according to the U.S. Food and Drug Administration (FDA). Curaleaf acknowledged that the product’s shelf life might be shorter than initially projected.
Initially, the recalled cannabis flower passed a 30-day stability test conducted after its distribution. Curaleaf stated that all products leaving its cultivation facilities comply with Connecticut state standards for contaminants, including pesticides, heavy metals, and microbial levels. The company is collaborating with the Connecticut Department of Consumer Protection to investigate the issue further.
The recalled product has a batch number of 2412267F4-AT and an expiration date of March 3, 2026. Patients who purchased the product can return it to any Curaleaf dispensary in Stamford, Manchester, Groton, or Hartford. Customers with health concerns are advised to consult their medical professionals and can reach out to Connecticut’s Medical Marijuana Program for further assistance.
Connecticut regulations require cannabis retailers to test their products for contaminants, including mold and yeast. However, details on failed tests are not made publicly available, making it difficult to ascertain the overall failure rate. In states that disclose such data, failure rates can reach as high as 15% in some instances.
In 2022, Connecticut lawmakers increased the acceptable mold levels from 10,000 to 100,000 colony-forming units (CFU) per gram to enhance public health safety. In a separate issue, Analytics Labs and other cannabis testing facilities in Massachusetts faced a lawsuit for allegedly inflating THC content and underreporting contaminants, claims that Analytics Labs denied.
Since 2022, Curaleaf has recalled cannabis products in several states, including New York, Arizona, and Pennsylvania, amid ongoing scrutiny in the industry.
English 
Spanish 
German 
Czech